close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

233.94 -1.10 (-0.47%)
Delayed Quote Updated: 10:23 AM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
20 21 Next >
News headline image
ResMed's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Why NYSE:RMD provides a good dividend, while having solid fundamentals. ↗
Exploring RESMED INC (NYSE:RMD)'s dividend characteristics. 
Via Chartmill
News headline image
FDA Identifies ResMed's Recall Of Certain Ventilator Device Masks With Magnets As Most Serious ↗
ResMed (NYSE: RMD) recalls certain respiratory masks with magnets due to potential interference with medical devices. FDA Class I recall. 
Via Benzinga
Topics Product Recall
News headline image
If You Invested $100 In This Stock 15 Years Ago, You Would Have $900 Today ↗
 
Via Benzinga
News headline image
Demystifying ResMed: Insights From 5 Analyst Reviews ↗
 
Via Benzinga
News headline image
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges. 
Via MarketBeat
Topics ETFs
News headline image
Uncovering Dividend Opportunities with NYSE:RMD. ↗
Why RESMED INC (NYSE:RMD) qualifies as a good dividend investing stock. 
Via Chartmill
News headline image
$1000 Invested In ResMed 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
(RMD) - Analyzing ResMed's Short Interest ↗
 
Via Benzinga
News headline image
Top Picks 2024: ResMed ↗
ResMed is the market leader in continuous positive airway pressure machines. ResMed has enjoyed a steadily growing market throughout its history, and investors have often paid sky-high valuations for... 
Via Talk Markets
News headline image
ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024
From ResMed Inc.
Via GlobeNewswire
News headline image
ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
From ResMed Inc.
Via GlobeNewswire
News headline image
ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices
ResMed’s masks with magnets are safe when used in accordance with the updated Instructions for Use 
From ResMed Inc.
Via GlobeNewswire
News headline image
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $17,000 Today ↗
 
Via Benzinga
News headline image
ResMed Secures Significant Victory in Patent Fight Against New York University
From ResMed Inc.
Via GlobeNewswire
News headline image
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
From ResMed Inc.
Via GlobeNewswire
News headline image
Why NYSE:RMD qualifies as a good dividend investing stock. ↗
Is RESMED INC (NYSE:RMD) a Good Fit for Dividend Investing? 
Via Chartmill
News headline image
Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion ↗
Sen. Tommy Tuberville bought 3 tranches of put options to sell Tesla shares at $190 a day ahead of Q3 results that set in motion a stock slump. 
Via Benzinga
News headline image
Why the dividend investor may take a look at NYSE:RMD. ↗
Analyzing RESMED INC (NYSE:RMD)'s Dividend Potential. 
Via Chartmill
News headline image
Is NYSE:RMD a Good Fit for Dividend Investing? ↗
Analyzing RESMED INC (NYSE:RMD)'s Dividend Potential. 
Via Chartmill
News headline image
ResMed Adopts New Operating Model to Accelerate Long-term Growth
From ResMed Inc.
Via GlobeNewswire
News headline image
2 Monster Stocks to Buy Without Any Hesitation ↗
Down 33% and 44%, these two stocks look too good to pass up today. 
Via The Motley Fool
News headline image
How Sleep Device Player ResMed Is Gaining Philips' Market Share In Flow Generator Market - Analysts Weigh In ↗
Needham analyst Mike Matson reiterated a Buy rating on ResMed Inc. (NYSE: RMD)  
Via Benzinga
News headline image
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact? ↗
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story. 
Via Investor's Business Daily
News headline image
Expert Ratings for ResMed ↗
 
Via Benzinga
News headline image
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024
From ResMed Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For October 26, 2023 ↗
Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnings at $2.57 per share on revenue of $49.83 billion. 
Via Benzinga
News headline image
3 Stocks to Buy From the ‘Buy the Dip’ ETF ↗
It’s a lot harder than it looks to buy the dip. Using artificial intelligence to do this makes these three stocks a buy. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2023 ↗
 
Via Benzinga
News headline image
Exxon Mobil To Rally Around 23%? Here Are 10 Other Analyst Forecasts For Thursday ↗
Cantor Fitzgerald cut Hyliion Holdings Corp. (NYSE: HYLN) price target from $2 to $1. Cantor Fitzgerald analyst Andres Sheppard downgraded the stock from Neutral to Underweight. Hyliion shares fell... 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.